Stay updated on PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer release identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T13:46:24.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.” It does not change the study information.
    Difference
    0.6%
    Check dated 2026-10-24T15:28:37.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The website footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-17T15:18:24.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T15:24:15.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    An entry for revision v3.7.0 has been added to the study history. The previous revision v3.6.6 is no longer listed.
    Difference
    0.1%
    Check dated 2026-09-19T18:33:46.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.6.6 was added to the record history, replacing the previous revision entry 'v3.6.5'. This reflects a minor update to the page's revision metadata rather than a change to the study data.
    Difference
    0.1%
    Check dated 2026-08-29T19:02:20.000Z thumbnail image

Stay in the know with updates to PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.